CA
CHI Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $7.66M | Buy |
215,000
+130,000
| +153% | +$4.63M | 3.04% | 9 |
|
2023
Q2 | $3.92M | Buy |
+85,000
| New | +$3.92M | 1.19% | 16 |
|
2021
Q2 | – | Sell |
-2,000
| Closed | -$228K | – | 21 |
|
2021
Q1 | $228K | Sell |
2,000
-1,000
| -33% | -$114K | 0.05% | 21 |
|
2020
Q4 | $415K | Sell |
3,000
-4,500
| -60% | -$623K | 0.12% | 19 |
|
2020
Q3 | $616K | Sell |
7,500
-5,500
| -42% | -$452K | 0.22% | 18 |
|
2020
Q2 | $1.02M | Sell |
13,000
-26,362
| -67% | -$2.06M | 0.4% | 14 |
|
2020
Q1 | $1.75M | Buy |
39,362
+862
| +2% | +$38.3K | 4.12% | 7 |
|
2019
Q4 | $1.64M | Buy |
38,500
+14,500
| +60% | +$619K | 1.24% | 7 |
|
2019
Q3 | $1.03M | Buy |
+24,000
| New | +$1.03M | 1% | 11 |
|